000 01481 a2200421 4500
005 20250517031630.0
264 0 _c20160509
008 201605s 0 0 eng d
022 _a1365-2141
024 7 _a10.1111/bjh.13480
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUgocsai, Peter
245 0 0 _aBiomodulatory metronomic therapy induces PET-negative remission in chemo- and brentuximab-refractory Hodgkin lymphoma.
_h[electronic resource]
260 _bBritish journal of haematology
_cJan 2016
300 _a290-3 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdult
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBrentuximab Vedotin
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHodgkin Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunoconjugates
_xadministration & dosage
650 0 4 _aImmunologic Factors
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aPositron-Emission Tomography
650 0 4 _aRemission Induction
650 0 4 _aSalvage Therapy
_xmethods
700 1 _aWolff, Daniel
700 1 _aMenhart, Karin
700 1 _aHellwig, Dirk
700 1 _aHoller, Ernst
700 1 _aHerr, Wolfgang
700 1 _aReichle, Albrecht
773 0 _tBritish journal of haematology
_gvol. 172
_gno. 2
_gp. 290-3
856 4 0 _uhttps://doi.org/10.1111/bjh.13480
_zAvailable from publisher's website
999 _c24871848
_d24871848